Copyright © 2000 by the European Society of Cardiology.
C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men
a Mayday University Hospital, Surrey, UK
b Public Health Sciences, St George's Hospital Medical School, London, UK
c Medical Research Council Epidemiology Unit (South Wales), Llandough Hospital, Glamorgan, U.K.
revised October 18, 1999; accepted October 20, 1999
Abstract
Background There is much interest in reported associations between serum C-reactive protein and incident ischaemic heart disease. It is uncertain what this association represents. We aimed to assess the effect of confounding from a number of different sources in the Caerphilly Prospective Heart Disease Study and in particular whether the low grade inflammation indicated by C-reactive protein may be the mechanism whereby non-circulating risk factors may influence pathogenesis of ischaemic heart disease.
Methods Plasma specimens collected during 1979–83 from 1395 men with sufficient sample remaining were assayed for serum C-reactive protein by ELISA. Subsequent mortality and incident ischaemic heart disease events were ascertained from death certificates, hospital records and electrocardiographic changes at 5-yearly follow-up examinations.
Results There was a positive association between C-reactive protein and incident ischaemic heart disease (P<0·005) mainly with fatal disease (P<0·002). There was also a positive association with all-cause mortality (P<0·0001). C-reactive protein was significantly associated with a number of non-circulating risk factors including body mass index (P<0·0001), smoking (P<0·0001), low forced expiratory volume in 1s (P<0·0001), height (P=0·025), low childhood social class (P=0·014) and age (P=0·036). C-reactive protein was also associated positively with circulating risk factors including viscosity, leukocyte count, fibrinogen (all P<0·0001) and insulin (P=0·0058). After adjustment for non-circulating risk factors the association with all-incident ischaemic heart disease and ischaemic heart disease death became non-significant, but the association with all-cause mortality remained (P=0·033). Further adjustment for fibrinogen however removed any hint of an increasing trend in odds for all three outcomes.
Conclusion C-reactive protein levels are raised in association with a variety of established cardiovascular risk factors. Neither C-reactive protein nor the systemic inflammation it represents appears to play a direct role in the development of ischaemic heart disease.
f1 Correspondence: Dr M. A. Mendall, Mayday University Hospital, Mayday Rd, Thornton Heath, Surrey CR7 7YE, U.K.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. K. Butland, D. P. Strachan, and A. R. Rudnicka C-reactive protein, obesity, atopy and asthma symptoms in middle-aged adults Eur. Respir. J., July 1, 2008; 32(1): 77 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Petersen, A. L. Marsland, J. Flory, E. Votruba-Drzal, M. F. Muldoon, and S. B. Manuck Community Socioeconomic Status is Associated With Circulating Interleukin-6 and C-Reactive Protein Psychosom Med, July 1, 2008; 70(6): 646 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Kunisaki, K. L. Rice, E. N. Janoff, T. S. Rector, and D. E. Niewoehner Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: A prospective study Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 55 - 64. [Abstract] [PDF]
|
|
|
|
 |
|
 P. M Ridker High-Sensitivity C-Reactive Protein as a Predictor of All-Cause Mortality: Implications for Research and Patient Care Clin. Chem., February 1, 2008; 54(2): 234 - 237. [Full Text] [PDF]
|
|
|
|
|
|
W. Koenig, N. Khuseyinova, J. Baumert, and C. Meisinger Prospective Study of High-Sensitivity C-Reactive Protein as a Determinant of Mortality: Results from the MONICA/KORA Augsburg Cohort Study, 1984-1998 Clin. Chem., February 1, 2008; 54(2): 335 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Memoli, A. Procino, P. Calabro, P. Esposito, G. Grandaliano, G. Pertosa, M. D. Prete, M. Andreucci, S. D. Lillo, G. Ferulano, et al. Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1030 - E1035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J John, A. M. Abulafi, A. Poullis, and M. A. Mendall Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people Gut, July 1, 2007; 56(7): 1034 - 1035. [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Yanbaeva, M. A. Dentener, E. C. Creutzberg, G. Wesseling, and E. F. M. Wouters Systemic Effects of Smoking Chest, May 1, 2007; 131(5): 1557 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Deutsch Evaluation of the Effect of Neptune Krill Oil on Chronic Inflammation and Arthritic Symptoms J. Am. Coll. Nutr., February 1, 2007; 26(1): 39 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. van Ree, L. H. Oterdoom, A. P. J. de Vries, R. T. Gansevoort, J. J. H. van der Heide, W. J. van Son, R. J. Ploeg, P. E. de Jong, R. O. B. Gans, S. J. L. Bakker, et al. Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients Nephrol. Dial. Transplant., January 1, 2007; 22(1): 246 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Sinning, C. Bickel, C.-M. Messow, R. Schnabel, E. Lubos, H. J. Rupprecht, C. Espinola-Klein, K. J. Lackner, L. Tiret, T. Munzel, et al. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study Eur. Heart J., December 2, 2006; 27(24): 2962 - 2968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hong, R. A. Nelesen, P. L. Krohn, P. J. Mills, and J. E. Dimsdale The Association of Social Status and Blood Pressure With Markers of Vascular Inflammation Psychosom Med, July 1, 2006; 68(4): 517 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Broekhuizen, E F M Wouters, E C Creutzberg, and A M W J Schols Raised CRP levels mark metabolic and functional impairment in advanced COPD Thorax, January 1, 2006; 61(1): 17 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Wannamethee, G. D.O. Lowe, A. G. Shaper, A. Rumley, L. Lennon, and P. H. Whincup Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease Eur. Heart J., September 1, 2005; 26(17): 1765 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Laaksonen, L. Niskanen, K. Nyyssonen, K. Punnonen, T.-P. Tuomainen, and J. T. Salonen C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study Eur. Heart J., September 1, 2005; 26(17): 1783 - 1789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nasir, E. Guallar, A. Navas-Acien, M. H. Criqui, and J. A.C. Lima Relationship of Monocyte Count and Peripheral Arterial Disease: Results From the National Health and Nutrition Examination Survey 1999-2002 Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1966 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B Sorensen, A. Raben, S. Stender, and A. Astrup Effect of sucrose on inflammatory markers in overweight humans Am. J. Clinical Nutrition, August 1, 2005; 82(2): 421 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ravaglia, P. Forti, F. Maioli, N. Brunetti, M. Martelli, L. Servadei, L. Bastagli, M. Bianchin, and E. Mariani Serum C-Reactive Protein and Cognitive Function in Healthy Elderly Italian Community Dwellers J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2005; 60(8): 1017 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cushman, A. M. Arnold, B. M. Psaty, T. A. Manolio, L. H. Kuller, G. L. Burke, J. F. Polak, and R. P. Tracy C-Reactive Protein and the 10-Year Incidence of Coronary Heart Disease in Older Men and Women: The Cardiovascular Health Study Circulation, July 5, 2005; 112(1): 25 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F L Fimognari, L Moro, R Antonelli Incalzi, D D Sin, W Q Gan, S F P Man, and A Senthilselvan COPD, restrictive syndrome and inflammation Thorax, July 1, 2005; 60(7): 612 - 613. [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Okin, M. J. Roman, L. G. Best, E. T. Lee, J. M. Galloway, B. V. Howard, and R. B. Devereux C-Reactive Protein and Electrocardiographic ST-Segment Depression Additively Predict Mortality: The Strong Heart Study J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1787 - 1793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Kritchevsky, M. Cesari, and M. Pahor Inflammatory markers and cardiovascular health in older adults Cardiovasc Res, May 1, 2005; 66(2): 265 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kistorp, I. Raymond, F. Pedersen, F. Gustafsson, J. Faber, and P. Hildebrandt N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults JAMA, April 6, 2005; 293(13): 1609 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans, and D. de Zeeuw Biochemical risk markers: a novel area for better prediction of renal risk? Nephrol. Dial. Transplant., March 1, 2005; 20(3): 497 - 508. [Full Text] [PDF]
|
|
|
|
|
|
W. Q. Gan, S.F. P. Man, and D. D. Sin The Interactions Between Cigarette Smoking and Reduced Lung Function on Systemic Inflammation Chest, February 1, 2005; 127(2): 558 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Fortmann, E. Ford, M. H. Criqui, A. R. Folsom, T. B. Harris, Y. Hong, T. A. Pearson, D. Siscovick, F. Vinicor, and P. F. Wilson CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report From the Population Science Discussion Group Circulation, December 21, 2004; 110(25): e554 - e559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Meurman, M. Sanz, and S.-J. Janket ORAL HEALTH, ATHEROSCLEROSIS, AND CARDIOVASCULAR DISEASE Crit. Rev. Oral. Biol. Med., November 1, 2004; 15(6): 403 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Kony, M Zureik, F Driss, C Neukirch, B Leynaert, and F Neukirch Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study Thorax, October 1, 2004; 59(10): 892 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Douglas, A. J. Taylor, and P. G. O'Malley Relationship Between Depression and C-Reactive Protein in a Screening Population Psychosom Med, September 1, 2004; 66(5): 679 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K P Morgan, A Kapur, and K J Beatt Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention Heart, July 1, 2004; 90(7): 732 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W Q Gan, S F P Man, A Senthilselvan, and D D Sin Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis Thorax, July 1, 2004; 59(7): 574 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.W.G Yarnell, C.C Patterson, P.M Sweetnam, and G.D.O Lowe Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies Eur. Heart J., June 2, 2004; 25(12): 1049 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Danesh, J. G. Wheeler, G. M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G. D.O. Lowe, M. B. Pepys, and V. Gudnason C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease N. Engl. J. Med., April 1, 2004; 350(14): 1387 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Block, C. Jensen, M. Dietrich, E. P. Norkus, M. Hudes, and L. Packer Plasma C-Reactive Protein Concentrations in Active and Passive Smokers: Influence of Antioxidant Supplementation J. Am. Coll. Nutr., April 1, 2004; 23(2): 141 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Milani, C. J. Lavie, and M. R. Mehra Reduction in C-reactive protein through cardiac rehabilitation and exercise training J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1056 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Backes, P. A Howard, and P. M Moriarty Role of C-Reactive Protein in Cardiovascular Disease Ann. Pharmacother., January 1, 2004; 38(1): 110 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Blake, N. Rifai, J. E. Buring, and P. M Ridker Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events Circulation, December 16, 2003; 108(24): 2993 - 2999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chandalia, A. V. Cabo-Chan Jr, S. Devaraj, I. Jialal, S. M. Grundy, and N. Abate Elevated Plasma High-Sensitivity C-Reactive Protein Concentrations in Asian Indians Living in the United States J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3773 - 3776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Frohlich, M. Sund, H. Lowel, A. Imhof, A. Hoffmeister, and W. Koenig Independent association of various smoking characteristics with markers of systemic inflammation in men: Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95) Eur. Heart J., July 2, 2003; 24(14): 1365 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Slade, E. M. Ghezzi, G. Heiss, J. D. Beck, E. Riche, and S. Offenbacher Relationship Between Periodontal Disease and C-Reactive Protein Among Adults in the Atherosclerosis Risk in Communities Study Arch Intern Med, May 26, 2003; 163(10): 1172 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. L. Biondi-Zoccai, A. Abbate, G. Liuzzo, and L. M. Biasucci Atherothrombosis, inflammation, and diabetes J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1071 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Imhof, M. Frohlich, H. Loewel, N. Helbecque, M. Woodward, P. Amouyel, G. D.O. Lowe, and W. Koenig Distributions of C-reactive Protein Measured by High-Sensitivity Assays in Apparently Healthy Men and Women from Different Populations in Europe Clin. Chem., April 1, 2003; 49(4): 669 - 672. [Full Text] [PDF]
|
|
|
|
|
|
P. M Ridker Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention Circulation, January 28, 2003; 107(3): 363 - 369. [Full Text] [PDF]
|
|
|
|
|
|
G. Engstrom, L. Janzon, G. Berglund, P. Lind, L. Stavenow, B. Hedblad, and F. Lindgarde Blood Pressure Increase and Incidence of Hypertension in Relation to Inflammation-Sensitive Plasma Proteins Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 2054 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Ridker, N. Rifai, L. Rose, J. E. Buring, and N. R. Cook Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events N. Engl. J. Med., November 14, 2002; 347(20): 1557 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Engstrom, P. Lind, B. Hedblad, P. Wollmer, L. Stavenow, L. Janzon, and F. Lindgarde Lung Function and Cardiovascular Risk: Relationship With Inflammation-Sensitive Plasma Proteins Circulation, November 12, 2002; 106(20): 2555 - 2560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Koenig and M. B. Pepys C-Reactive Protein Risk Prediction: Low Specificity, High Sensitivity Ann Intern Med, April 2, 2002; 136(7): 550 - 552. [Full Text] [PDF]
|
|
|
|
|
|
P. Libby, P. M. Ridker, and A. Maseri Inflammation and Atherosclerosis Circulation, March 5, 2002; 105(9): 1135 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lindmark, E. Diderholm, L. Wallentin, and A. Siegbahn Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery Disease: Effects of an Early Invasive or Noninvasive Strategy JAMA, November 7, 2001; 286(17): 2107 - 2113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.J. Koch and C. Raschka Over-training syndrome as a model of a coronary inflammation process? Eur. Heart J., August 2, 2001; 22(16): 1512 - 1512. [PDF]
|
|
|
|
|
|
P. M. Ridker High-Sensitivity C-Reactive Protein : Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease Circulation, April 3, 2001; 103(13): 1813 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Rifai and P. M. Ridker High-Sensitivity C-Reactive Protein: A Novel and Promising Marker of Coronary Heart Disease Clin. Chem., March 1, 2001; 47(3): 403 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.M. Biasucci C-reactive protein and dangerous liaisons Eur. Heart J., October 1, 2000; 21(19): 1560 - 1562. [PDF]
|
|